Results 31 to 40 of about 2,699 (183)
Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature Review [PDF]
, 2022 INTRODUCTION: Psoriasis is a common inflammatory skin disease that significantly impacts patients’ psychosocial wellbeing. Despite increasingly effective treatment options, the recurrence of plaques after discontinuation of therapy in many patients ...
Schreidah, Celine M. +4 more
core +1 more source
Frontiers in Immunology, 2023 Mycoses fungoides (MF) and Sézary syndrome (SS) are cutaneous T-cell lymphomas that are often challenging to manage given the absence of reliably curative therapies, at times high symptom burden with significant detriment to quality of life, and need for
Robert Stuver, Shamir Geller
doaj +1 more source
Current Research in Toxicology, 2021 The purpose of the present study was to investigate the vesicant countermeasure effects of hydrocortisone (HC) and ebselen (EB-1), administered as monotherapy or as a combination treatment.
Hemanta C Rao Tumu +2 more
doaj +1 more source
Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions
Acta Dermato-Venereologica, 2022 Chlormethine is a bifunctional cytotoxic alkylating agent that binds to DNA, resulting in cell death (apoptosis). Chlormethine (also known as mechlorethamine) gel (CL gel) was approved in the European Union in 2017 and was first used in 2019.
Marios Koumourtzis +3 more
doaj +1 more source
, 2022 INTRODUCTION: Treatment of early-stage mycosis fungoides (MF) requires safe, skin-directed therapies. Medication side effects can lead to underutilization of effective therapies.
Alexander-Savino, Carolina V +4 more
core +1 more source